Search Results 271-280 of 3009 for ☂[광고텔레:GTTVTT] 홀덤솔루션 구글대포폰광고 개인장삽니다 스포츠사이트 통장삽니다 상단대행☂

1. Everolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

   Everolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Brentuximab vedotin may interfere with the ability of ...

2. Clinical Study of the Treovance Stent-Graft for Patients With Abdominal Aortic Aneurysms

   About this study. The purpose of this clinical trial is to assess and evaluate the safety and efficacy of the Treovance Stent-Graft with Navitel Delivery ...

3. Collection of Mayo SDH Mutant Paraganglioma Tumor Tissue for Establishment of Cultured Tumor Cell Lines

   About this study. The purpose of this study is to to develop cultured human tumor cell lines from paraganglioma/ pheochromocytoma (PGL) tumors.

4. Pazopanib in Treating Patients with Metastatic Non-Clear Cell Kidney Cancer - Mayo Clinic

   Pazopanib hydrochloride may also stop the growth of kidney cancer by blocking blood flow to the tumor. Participation eligibility. Participant eligibility ...

5. Subharmonics and Subharmonic Aided Pressure Estimation for Identifying Portal Hypertension - Mayo Clinic

   About this study. The purpose of this study is to evaluate use of subharmonic imaging and the SHAPE technique for identifying portal hypertension (PH).

6. Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma - Mayo Clinic

   Tipifarnib will be administered until disease progression then followed approximately every 12 weeks for survival until either death or 12 months after accrual ...

7. Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells - Mayo Clinic

   Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells · Overview · Participation eligibility.

8. Study of Vadastuximab Talirine (SGN-CD33A; 33A) in Combination With Azacitidine in Patients With Previously Untreated Higher Risk MDS - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

9. Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

   Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck · Overview · Participation eligibility.

10. A Study to Evaluate the Relationship of the Glucose Threshold for Insulin Secretion with Beta-cell Function - Mayo Clinic

    The purpose of this study is to determine if the set-point for fasting insulin secretion, and the subsequent response to hyperglycemia, is altered in people ...